Although many of the above figures need to be interpreted with caution because of lack of validation (i-/c-ELISAs), potential specificity loss (RBT), inability to detect non-agglutinating antibodies (SAT) or IgG (IgM LFA), they clearly indicate the importance of brucellosis in characteristic risk groups. This evidence concerns the gene CD40LG and brucellosis.